DV
Dividend Vision

KNSA — Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc (KNSA)

Total return is 294.2% over the past 8.2 years, 71.3 points ahead of SPY at 222.9%. Its deepest 1-year drawdown was 21.1%.

KNSA is an equity fund focused on international healthcare companies, specifically tracking Kiniksa Pharmaceuticals International, plc. The fund operates as a stock-type investment with an international healthcare sector focus, though specific details on distribution frequency, yield profile, and expense ratio are not currently available. This fund appeals to investors seeking exposure to international pharmaceutical and healthcare sectors, though the limited data suggests careful review of current fund documentation is warranted before evaluation.

KNSA key facts

Asset type
Stock
Asset class
Equity
Inception date
05/24/2018
Distribution frequency
None
Last close
$76.75
Market cap
$5,988,343,296
Average volume
403529.0
Beta
0.085
Payout ratio
0.0
P/E ratio
77.5253
Forward P/E
71.4286
EPS
$0.99